These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 33044649

  • 1. Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI.
    Chouhan MD, Taylor SA, Bainbridge A, Walker-Samuel S, Davies N, Halligan S, Lythgoe MF, Mookerjee RP.
    Eur Radiol; 2021 Apr; 31(4):2518-2528. PubMed ID: 33044649
    [Abstract] [Full Text] [Related]

  • 2. Liver perfusion MRI in a rodent model of cirrhosis: Agreement with bulk-flow phase-contrast MRI and noninvasive evaluation of inflammation in chronic liver disease using flow-sensitive alternating inversion recovery arterial spin labelling and tissue T1.
    Chouhan MD, Ramasawmy R, Bainbridge A, Campbell-Washburn A, Halligan S, Davies N, Walker-Samuel S, Lythgoe MF, Mookerjee RP, Taylor SA.
    NMR Biomed; 2021 Feb; 34(2):e4423. PubMed ID: 33029872
    [Abstract] [Full Text] [Related]

  • 3. Caval Subtraction 2D Phase-Contrast MRI to Measure Total Liver and Hepatic Arterial Blood Flow: Proof-of-Principle, Correlation With Portal Hypertension Severity and Validation in Patients With Chronic Liver Disease.
    Chouhan MD, Mookerjee RP, Bainbridge A, Punwani S, Jones H, Davies N, Walker-Samuel S, Patch D, Jalan R, Halligan S, Lythgoe MF, Taylor SA.
    Invest Radiol; 2017 Mar; 52(3):170-176. PubMed ID: 27805917
    [Abstract] [Full Text] [Related]

  • 4. Use of Caval Subtraction 2D Phase-Contrast MR Imaging to Measure Total Liver and Hepatic Arterial Blood Flow: Preclinical Validation and Initial Clinical Translation.
    Chouhan MD, Mookerjee RP, Bainbridge A, Walker-Samuel S, Davies N, Halligan S, Lythgoe MF, Taylor SA.
    Radiology; 2016 Sep; 280(3):916-23. PubMed ID: 27171018
    [Abstract] [Full Text] [Related]

  • 5. Improved hepatic arterial fraction estimation using cardiac output correction of arterial input functions for liver DCE MRI.
    Chouhan MD, Bainbridge A, Atkinson D, Punwani S, Mookerjee RP, Lythgoe MF, Taylor SA.
    Phys Med Biol; 2017 Feb 21; 62(4):1533-1546. PubMed ID: 28002045
    [Abstract] [Full Text] [Related]

  • 6. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA, Semus H, Pitts K, Peng Y, Sandoval J, Chapo J, Plato CF.
    Can J Physiol Pharmacol; 2010 Jun 21; 88(6):636-43. PubMed ID: 20628429
    [Abstract] [Full Text] [Related]

  • 7. Haemodynamic and renal evolution of the bile duct-ligated rat.
    Martínez-Prieto C, Ortíz MC, Fortepiani LA, Ruiz-Maciá J, Atucha NM, García-Estañ J.
    Clin Sci (Lond); 2000 May 21; 98(5):611-7. PubMed ID: 10781394
    [Abstract] [Full Text] [Related]

  • 8. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM, Vilaseca M, Lafoz E, Garcia-Calderó H, Viegas Haute G, Fernández-Iglesias A, Rodrigues de Oliveira J, García-Pagán JC, Bosch J, Gracia-Sancho J.
    Gastroenterology; 2018 Nov 21; 155(5):1564-1577. PubMed ID: 30055171
    [Abstract] [Full Text] [Related]

  • 9. Cardiac-induced liver deformation as a measure of liver stiffness using dynamic imaging without magnetization tagging-preclinical proof-of-concept, clinical translation, reproducibility and feasibility in patients with cirrhosis.
    Chouhan MD, Fitzke HE, Bainbridge A, Atkinson D, Halligan S, Davies N, Lythgoe MF, Mookerjee RP, Menys A, Taylor SA.
    Abdom Radiol (NY); 2021 Oct 21; 46(10):4660-4670. PubMed ID: 34148103
    [Abstract] [Full Text] [Related]

  • 10. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat.
    Harry D, Anand R, Holt S, Davies S, Marley R, Fernando B, Goodier D, Moore K.
    Hepatology; 1999 Nov 21; 30(5):1198-205. PubMed ID: 10534341
    [Abstract] [Full Text] [Related]

  • 11. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y, Kanazawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Kidokoro H, Harimoto H, Fukuda T, Matsushita Y, Nakatsuka K, Sakamoto C.
    J Gastroenterol Hepatol; 2009 Nov 21; 24(11):1791-7. PubMed ID: 19686420
    [Abstract] [Full Text] [Related]

  • 12. Beneficial Effects of Adrenal Androgen Supplement in Bleeding Cirrhotic Rats.
    Huang HC, Hsu SJ, Chang CC, Tsai MH, Lee FY, Hou MC, Lee SD.
    Shock; 2018 Dec 21; 50(6):720-728. PubMed ID: 29394240
    [Abstract] [Full Text] [Related]

  • 13. LPS-induced imbalanced expression of hepatic vascular stress genes in cirrhosis: possible mechanism of increased susceptibility to endotoxemia.
    Baveja R, Keller S, Yokoyama Y, Sonin N, Clemens MG, Zhang JX.
    Shock; 2002 Apr 21; 17(4):316-21. PubMed ID: 11954834
    [Abstract] [Full Text] [Related]

  • 14. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T, Payer BA, Schwabl P, Hayden H, Horvatits T, Jäger B, Hummel T, Mitterhauser M, Trauner M, Fuhrmann V, Angermayr B, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    Liver Int; 2013 Apr 21; 33(4):561-8. PubMed ID: 23331709
    [Abstract] [Full Text] [Related]

  • 15. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
    Møller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F.
    Liver; 2000 Feb 21; 20(1):51-9. PubMed ID: 10726961
    [Abstract] [Full Text] [Related]

  • 16. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
    Moreau R, Cailmail S, Valla D, Lebrec D.
    Aliment Pharmacol Ther; 1997 Oct 21; 11(5):993-7. PubMed ID: 9354212
    [Abstract] [Full Text] [Related]

  • 17. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E, Rodríguez-Vilarrupla A, Gracia-Sancho J, Tripathi D, García-Calderó H, Bosch J, García-Pagán JC.
    Hepatology; 2013 Oct 21; 58(4):1424-35. PubMed ID: 23703868
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G, Economou M, Paraskevi K, Konstantinos P, Pappas C, Katsaraki A, Tsianos EV.
    J Gastroenterol Hepatol; 2005 Jul 21; 20(7):1075-81. PubMed ID: 15955217
    [Abstract] [Full Text] [Related]

  • 20. Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765.
    Gómez-Hurtado I, Zapater P, Portune K, Juanola O, Fernández-Iglesias A, González-Navajas JM, Gracia-Sancho J, Sanz Y, Francés R.
    Eur J Nutr; 2019 Jun 21; 58(4):1647-1658. PubMed ID: 29748815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.